Grifols earns Platinum rating in EcoVadis sustainability assessment

Barcelona, October 23, 2025 - EcoVadis, one of the world’s leading platforms for corporate sustainability ratings, has awarded Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), a global healthcare company and leader in plasma-derived medicines, the highest distinction in its sustainability ranking.

This rating, the highest in Grifols’ history with a score of 86 out of 100, underscores the company’s progress in environmental, social, and governance (ESG) matters and highlights the strength of its strategy to integrate sustainability across its business model, global operations and supplier network.

Over the past two years, Grifols had been awarded the Gold Medal for Excellence in Sustainability. This year, the company has been elevated to the Platinum category, an honor reserved for only 1% of the approximately 50,000 companies assessed by EcoVadis globally.

EcoVadis medals evaluate the strength of a company’s management system based on sustainability criteria and its performance relative to other companies in the EcoVadis database over the past 12 months.

This year, Grifols stood out with a score of 92 out of 100 in the environmental category and showed significant improvement in labor practices and human rights, increasing its score from 80 to 87. The most notable progress was in the area of sustainable procurement, where the company’s score rose from 60 to 79 out of 100, reflecting Grifols’ commitment to transforming its value chain.

Grifols regularly reviews its evaluation, collaboration, and development processes with strategic suppliers to ensure its operations align with environmental, social, and ethical standards. This approach helps reduce risks and promotes transparency and innovation across its supply network. Additionally, the company’s ethics score increased from 70 to 81 out of 100, highlighting the strengthening of its culture of compliance, transparency, and governance.

Raimon Grifols, Vice Chairman of Grifols and member of the Board’s Sustainability, Communication and Reputation Committee, stated: “Sustainability is a non-negotiable pillar of our company. Since our founding more than 115 years ago, it has been part of our DNA. Today, we are especially grateful for this global recognition from such a prestigious platform as EcoVadis.”

This achievement adds to a series of recent accolades that position Grifols among the top-performing companies in sustainability. In 2024, the company ranked among the leading biotechnology firms in the Dow Jones Best-in-Class Indices (formerly DJSI), being included for the fourth and fifth consecutive years in the World and Europe indices, respectively.

Grifols also earned the Prime badge in ISS’s ESG rating, received a BBB rating from MSCI ESG Ratings, and was ranked among the best-performing companies by Sustainalytics, with a low ESG risk score. The company also participates annually in the Carbon Disclosure Project (CDP) and has been part of the FTSE4Good Index since 2018.